Rothschild & CO Asset Management Us Inc. Amicus Therapeutics, Inc. Transaction History

Rothschild & CO Asset Management Us Inc.

$6.56 Billion
Q4 2022

A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 666,214 shares of FOLD stock, worth $6.54 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

666,214

Previous 713,946 6.69%

Holding current value

$6.54 Million

Previous $7.45 Million 9.12%

% of portfolio

0.12%

Previous 0.13%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$9.89 - $12.7 $472,069 - $606,196	-47,732 Reduced 6.69%	666,214 $8.13 Million
Q3 2022 Nov 07, 2022	SELL	$9.82 - $12.75 $1.56 Million - $2.02 Million	-158,654 Reduced 18.18%	713,946 $7.45 Million
Q2 2022 Aug 09, 2022	SELL	$6.23 - $11.12 $261,753 - $467,206	-42,015 Reduced 4.59%	872,600 $9.37 Million
Q1 2022 May 13, 2022	SELL	$7.89 - $12.48 $2.36 Million - $3.74 Million	-299,502 Reduced 24.67%	914,615 $8.66 Million
Q4 2021 Feb 11, 2022	SELL	$9.82 - $12.44 $461,991 - $585,252	-47,046 Reduced 3.73%	1,214,117 $14 Million

Q3 2021 Nov 09, 2021	SELL	$8.74 - $11.84 $1.28 Million - $1.74 Million	-146,768 Reduced 10.42%	1,261,163 $12 Million
Q2 2021 Aug 16, 2021	BUY	$8.71 - $10.72 $2.28 Million - $2.81 Million	262,337 Added 22.9%	1,407,931 $13.6 Million
Q1 2021 May 14, 2021	SELL	$9.2 - $23.86 $3.1 Million - $8.04 Million	-336,873 Reduced 22.72%	1,145,594 $11.3 Million
Q4 2020 Feb 08, 2021	SELL	$13.47 - $24.89 $3.79 Million - $7 Million	-281,263 Reduced 15.95%	1,482,467 $34.2 Million
Q3 2020 Nov 09, 2020	BUY	$12.89 - $15.89 $248,428 - $306,247	19,273 Added 1.1%	1,763,730 $24.9 Million
Q2 2020 Aug 10, 2020	SELL	$8.86 - $15.69 $2.56 Million - $4.53 Million	-288,663 Reduced 14.2%	1,744,457 $26.3 Million
Q1 2020 May 14, 2020	SELL	$6.63 - $11.16 $1.11 Million - $1.87 Million	-167,787 Reduced 7.62%	2,033,120 $18.8 Million
Q4 2019 Feb 12, 2020	BUY	$7.48 - $10.75 $5.11 Million - $7.34 Million	682,567 Added 44.95%	2,200,907 $21.4 Million
Q3 2019 Nov 08, 2019	SELL	$8.02 - $13.25 $128,985 - $213,099	-16,083 Reduced 1.05%	1,518,340 $12.2 Million
Q2 2019 Jul 25, 2019	BUY	$10.96 - $14.4 $476,573 - $626,155	43,483 Added 2.92%	1,534,423 $19.2 Million
Q1 2019 May 08, 2019	SELL	$10.04 - $13.92 $305,205 - $423,154	-30,399 Reduced 2.0%	1,490,940 $20.3 Million
Q4 2018 Feb 05, 2019	BUY	$8.38 - $13.44 $181,452 - $291,016	21,653 Added 1.44%	1,521,339 $14.6 Million
Q3 2018 Nov 13, 2018	BUY	$11.6 - $16.54 $14.7 Million - $20.9 Million	1,264,173 Added 536.77%	1,499,686 $18.1 Million
Q2 2018 Aug 07, 2018	BUY	$13.13 - $17.09 $1.83 Million - $2.38 Million	139,382 Added 144.99%	235,513 $3.68 Million
Q1 2018 May 08, 2018	BUY	$13.76 - $17.12 $49,838 - $62,008	3,622 Added 3.92%	96,131 $1.45 Million
Q4 2017 Feb 12, 2018	BUY	$12.51 - $16.24 $1.16 Million - $1.5 Million	92,509	92,509 $1.33 Million

Others Institutions Holding FOLD

# of Institutions

273

Shares Held

325M

Call Options Held

841K

Put Options Held

353K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.75B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.

Account

Rothschild & CO Asset Management Us Inc. Amicus Therapeutics, Inc. Transaction History